US to start studies into three vaccine candidates from July

Authorities in the US are planning to fund and conduct studies into three experimental vaccines for the novel coronavirus, including that being developed by Oxford University's Jenner institute and AstraZeneca.

According to the Wall Street Journal, which cited John Mascola, the head of vaccine research at the National Institute of Allergy and Infectious Diseases, a vaccine being manufactured by Moderna Therapeutics would come first, starting from July, followed by the Oxford vaccine in August and another vaccine candidate from Johnson&Johnson in September.